Peptide Receptor Radionuclide Therapy (PRRT) Market Size Share Trends Forecast 2027

1. PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Peptide Receptor Radionuclide Therapy (PRRT) Market - Overview The Global Peptide Receptor Radionuclide Therapy (PRRT) Market, by Drug Type (Lutetium (Lu-177)-based), by Disease Indication (Pancreatic - Neuroendocrine Tumor, Gastrointestinal Tract - Neuroendocrine Tumor, and Others), by Distribution Channel (Hospital Pharmacies and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 231.5 million in 2018 and is expected to exhibit a CAGR of 27.3% during the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights. Increasing research and development regarding peptide receptor radionuclide therapy is expected to propel the market growth over the forecast period. For instance, in February 2017, ABX-CRO, an advanced pharmaceutical services company, in collaboration with ITM Isotopen Technologien Munchen AG, a biotechnology and radiopharmaceutical group of companies, initiated phase III clinical trial for evaluating efficacy and safety of peptide receptor radionuclide therapy (PRRT) with 177luedotreotide compared to targeted molecular therapy with everolimus in patients with inoperable, progressive, somatostatin receptor-positive (SSTR+), neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NET). The study is expected to be completed by May 2024 Browse 35 Market Data Tables and 26 Figures spread through 127 Pages and in-depth TOC on Global Peptide Receptor Radionuclide Therapy (PRRT) Market. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/peptide- receptor-radionuclide-therapy-prrt-market-2731 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Increasing adoption of inorganic growth strategies such as acquisition and collaboration by key players operating in the pharmaceutical industry is expected to drive growth of the global peptide receptor radionuclide therapy (PRRT) market. For instance, in May 2015, Ipsen, a global specialty-driven biotechnological company, strengthened its presence in the oncology field with the acquisition of OctreoPharm Sciences, a company developing innovative radiopharmaceuticals for the diagnosis and treatment of neuroendocrine tumors. Moreover, increasing incidence and prevalence of pancreatic neuroendocrine tumors, increasing research activity for developing more efficient drug products, increasing adoption of expansion strategies by manufacturers, and increasing product approvals are expected to drive growth of the market during the forecast period. For instance, in 2019, according to the Pancreatic Cancer Action Network reports, pancreatic neuroendocrine tumors are estimated to account for around 7 percent of all pancreatic tumors, globally. by Drug Neuroendocrine Tumor, Gastrointestinal Tract - Neuroendocrine Tumor, and Others), by Distribution Channel (Hospital Pharmacies and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027' Type (Lutetium (Lu-177)-based), by Disease Indication (Pancreatic - Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2731 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Takeaways of the Global Peptide Receptor Radionuclide Therapy (PRRT) Market: The global peptide receptor radionuclide therapy (PRRT) market is expected to exhibit a CAGR of 6.7% during the forecast period (2019–2027), owing to increasing initiatives by major players for development of effective drugs for the treatment of cancer. For instance, in July 2018, Clarity Pharmaceuticals Ltd. initiated phase 1 & 2 open label, non-randomized, single cohort, and multiple dose study to investigate the safety and tolerability of Cu-64 SARTATE and multiple doses in patients with meningioma. Furthermore, increasing collaborations between manufacturers and research institutes for research and development of new drugs based on peptide receptor radionuclide therapy (PRRT) is expected to drive the market growth. For instance, in May 2016, Romagnolo Scientific Institute for the Study and Treatment of Tumors (IRST) Srl conducted research on peptide receptor based drugs. Major players operating in the global peptide receptor radionuclide therapy (PRRT) market include Novartis AG (Advanced Accelerator Applications, S.A.) Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2731 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved